ScholarIQanswers from OpenAlex & ORCID
Peter Sever
ResearcherPublications, citations & collaboration network
Peter Sever is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Peter Sever have?
ScholarIQindexed works
Peter Sever has 341 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Peter Sever have?
ScholarIQcitation count
Peter Sever has 48,576 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Peter Sever?
ScholarIQh-index
Peter Sever has an h-index of 80 in OpenAlex.
What is the i10-index of Peter Sever?
ScholarIQi10-index
Peter Sever has an i10-index of 193 in OpenAlex.
What is the OpenAlex record for Peter Sever?
ScholarIQopenalex
The OpenAlex for Peter Sever is on the source record.
What are the most-cited papers on Peter Sever?
ScholarIQmost cited works
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine, Robert P. Giugliano, Anthony Keech, Narimon Honarpour, Stephen D. Wiviott, Sabina A. Murphy, Julia Kuder, Huei Wang, Thomas Liu, Scott M. Wasserman, Peter Sever, Terje R. Pedersen
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
Peter Sever, Björn Dahlöf, Neil R Poulter, Hans Wedel, Gareth Beevers, Mark J. Caulfield, Rory Collins, Sverre E. Kjeldsen, Arni Kristinsson, Gordon T. McInnes, Jesper Mehlsen, Markku S. Nieminen, Eoin OʼBrien, Jan Östergren
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
Björn Dahlöf, Peter Sever, Neil R Poulter, Hans Wedel, DG Beevers, Mark J. Caulfield, Rory Collins, Sverre E. Kjeldsen, Arni Kristinsson, Gordon T. McInnes, Jesper Mehlsen, Markku S. Nieminen, Eoin OʼBrien, Jan Östergren
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent, Lisa Blackwell, Roger S. Blumenthal, John Danesh, George Davey Smith, David L. DeMets, Stephen Evans, Malcolm Law, Stephen MacMahon, Seth S. Martin, Bruce Neal, Neil R Poulter, David Preiss, Paul M. Ridker, Ian Roberts, Anthony Rodgers, Peter Sandercock, Kenneth F. Schulz, Peter Sever, John Simes, Liam Smeeth, Nicholas Wald, Salim Yusuf, Richard Peto
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
Peter M. Rothwell, Sally C. Howard, Eamon Dolan, Eoin OʼBrien, Joanna E Dobson, Björn Dahlöf, Peter Sever, Neil R Poulter